[1] ZAPPA C,MOUSA S A.Non-small cell lung cancer:current treatment and future advances[J].Transl Lung Cancer Res,2016,5(3):288-300.
[2] 乐胜兵,吴密璐.非小细胞肺癌靶向治疗研究进展[J].现代肿瘤医学,2016,24(5):840-843.
[3] 陆舜,虞永峰,纪文翔.2015年肺癌诊疗指南:共识和争议[J].解放军医学杂志,2016,41(1):1-6.
[4] TENG F,LIU M,CUI G,et al.Clinical efficacy of iressa combined with radiotherapy in treatment of patients with non-small cell lung cancer and brain metastasis[J].J Clin Med Pract,2017,13(5):381-382.
[5] HIRSCH F R,SEQUIST L V,GORE I,et al.Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer:Results from the US IRESSA clinical access program(ICAP)[J].Cancer,2018,124(11):2407-2414.
[6] WERNER L,KELLER F A,BHURE U,et al.The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography(FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer[J].BMC Med Imaging,2017,17(1):41.
[7] NORMANNO N,DENIS M G,THRESS K S,et al.Guide to detecting epidermal growth factor receptor(EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer[J].Oncotarget,2017,8(7):12501-12506.
[8] TALSMA K,HAGEN P V,GROTENHUIS B A,et al.Comparison of the 6th and 7th editions of the UICC-AJCC TNM classification for esophageal cancer[J].Ann Surg Oncol,2012,19(7):2142-2148.
[9] ZHANG Q,ZHANG X,YAN H,et al.Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone onEGFR-mutant non-small cell lung cancer with brain metastasis[J].Thorac Cancer,2016,7(6):648-654.
[10] 张卉,张树才.非小细胞肺癌EGFR基因靶向治疗研究进展[J].中国肺癌杂志,2017,20(1):61-65.
[11] 邵慧,陈愉生,李鸿茹,等.晚期肺腺癌EGFR-TKIs靶向治疗临床疗效的研究[J].肿瘤学杂志,2016,22(8):627-631.
[12] 马玲,张琰,单莉,等.维吾尔族晚期非小细胞肺癌患者EGFR、KRAS基因突变状态及其与TKI靶向治疗效果的关系[J].山东医药,2016,56(31):66-68.
[13] SHODA K,ICHIKAWA D,FUJITA Y,et al.Monitoring the HER2,copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer[J].Gastric Cancer,2016,20(1):1-10.
[14] BRYCHTA N,KRAHN T,VON A O.Detection of KRAS mutations in circulating Tumor DNA by digital PCR in early stages of pancreatic cancer[J].Clin Chem,2016,62(11):1482.
[15] BAI H,MAO L,WANG H S,et al.Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages ⅢB to IV non-small-cell lung cancer[J].J Clin Oncol,2009,27(16):2653-2659.
[16] GAJI B,STEVANOVI J,ŽELJKO RADULOVI,et al.Haplotype identification and detection of mitochondrial DNA heteroplasmy in Varroa destructor,mites using ARMS and PCR-RFLP methods[J].Exp Appl Acarol,2016,70(3):287-297.
[17] WANG W,SONG Z,ZHANG Y.A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance[J].Cancer Med,2017,6(1):154-162. |